Cargando…
Use of silver nanoparticles increased inhibition of cell-associated HIV-1 infection by neutralizing antibodies developed against HIV-1 envelope proteins
BACKGROUND: HIV/AIDS pandemic is a worldwide public health issue. There is a need for new approaches to develop new antiviral compounds or other therapeutic strategies to limit viral transmission. The envelope glycoproteins gp120 and gp41 of HIV are the main targets for both silver nanoparticles (Ag...
Autores principales: | Lara, Humberto H, Ixtepan-Turrent, Liliana, Garza Treviño, Elsa N, Singh, Dinesh K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180349/ https://www.ncbi.nlm.nih.gov/pubmed/21923937 http://dx.doi.org/10.1186/1477-3155-9-38 |
Ejemplares similares
-
PVP-coated silver nanoparticles block the transmission of cell-free and cell-associated HIV-1 in human cervical culture
por: Lara, Humberto H, et al.
Publicado: (2010) -
Silver nanoparticles are broad-spectrum bactericidal and virucidal compounds
por: Lara, Humberto H, et al.
Publicado: (2011) -
Mode of antiviral action of silver nanoparticles against HIV-1
por: Lara, Humberto H, et al.
Publicado: (2010) -
Antiviral mode of action of bovine dialyzable leukocyte extract against human immunodeficiency virus type 1 infection
por: Lara, Humberto H, et al.
Publicado: (2011) -
Antiviral propierties of 5,5'-dithiobis-2-nitrobenzoic acid and bacitracin against T-tropic human immunodeficiency virus type 1
por: Lara, Humberto H, et al.
Publicado: (2011)